Characterization of efficacy and safety of pathogen inactivated and quarantine plasma in routine use for treatment of acquired immune thrombotic thrombocytopenic purpura.

Herbrecht, R; Ojeda-Uribe, M; Kientz, D; Fohrer, C; Bohbot, A; Hinschberger, O; Liu, K-L; Remy, E; Ernst, C; Lin, J-S; Corash, L; Cazenave, J P

Herbrecht, R; Ojeda-Uribe, M; Kientz, D; Fohrer, C; Bohbot, A; Hinschberger, O; Liu, K-L; Remy, E; Ernst, C; Lin, J-S; Corash, L; Cazenave, J P.

Afiliación

Herbrecht R; Centre de Competence des Microangiopathies d'Alsace, Strasbourg, France.
Ojeda-Uribe M; Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Kientz D; Centre de Competence des Microangiopathies d'Alsace, Strasbourg, France.
Fohrer C; CH Emile Muller, Mulhouse, France.
Bohbot A; EFS Alsace, Strasbourg, France.
Hinschberger O; Centre de Competence des Microangiopathies d'Alsace, Strasbourg, France.
Liu KL; Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Remy E; Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Ernst C; CH Emile Muller, Mulhouse, France.
Lin JS; CH Emile Muller, Mulhouse, France.
Corash L; EFS Alsace, Strasbourg, France.
Cazenave JP; Cerus Corporation, Concord, CA, USA.

Vox Sang ; 2018 May 21.

Article en En | MEDLINE | ID: mdl-29786866

Palabras clave

cardiac diseases; infection; plasmapheresis; thrombotic thrombocytopenic purpura; transfusion medicine; transfusion reaction

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Vox Sang Año: 2018 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google